Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

JP Morgan Downgrades Cyteir Therapeutics to Neutral

JP Morgan analyst Anupam Rama downgrades Cyteir Therapeutics (NASDAQ:CYT) from Overweight to Neutral.
byBenzinga Newsdesk
January 20, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

JP Morgan analyst Anupam Rama downgrades Cyteir Therapeutics (NASDAQ:CYT) from Overweight to Neutral.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Why Smart For Life Stock Is Racing Higher

By Erica Kollmann
April 8, 2:10 PM
Smart for Life will acquire Purely Optimal Nutrition, an eCommerce nutraceuticals company with operations in North America. The company expects the acquisition deal to close within the next eight weeks. "This acquisition is another validation of our ‘Buy-and-Build' strategy designed to establish Smart for Life as a major international force in the Health & Wellness sector," stated Darren Minton, CEO of Smart for Life.

SMFL